ACN vs ADSK Stock Comparison
Scores Breakdown
| Metric | ACN | ADSK |
|---|---|---|
| 📈 Growth | 22/30 | 28/30 |
| 💰 Profitability | 18/20 | 18/20 |
| 🏦 Financial Health | 18/20 | 12/20 |
| 💵 Valuation | 16/20 | 12/20 |
| ⚠️ Risk (lower is better) | 4/10 | 5/10 |
| Overall Score | 80/100 | 75/100 |
Side-by-Side Summaries
| ACN Analysis | ADSK Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, revenues moved from $16.41B (2024 Q4) to $18.72B (2026 Q3), a cumulative rise of about 14%. Net income increased from roughly $1.68B to $2.34B, up about 39%, signaling improving operating leverage as scale widens. The trend shows quarterly fluctuations but an overall positive trajectory with gradually rising profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver eight quarters, Revenues rose from roughly $1.50B to $1.93B, and Net Income grew from about $275M to $491M, delivering a clear top‑ and bottom‑line uptrend. The sequence shows steady sequential gains with only modest quarterly volatility, translating to ~29% revenue growth and ~78% net income growth across the period. 💰 Margins & Cash FlowGross margins run in the mid‑to‑high 80s percent range, with Gross Profit margin staying strong relative to Revenues. Operating leverage appears favorable as operating income remains healthy while R&D and other investments persist. Cash flow from operations is consistently positive, often in the hundreds of millions (e.g., ~$460–$564M), with occasional financing outflows; investing cash flow is modest and generally supportive of ongoing growth. 🛡️ Balance Sheet & LiquidityTotal assets hover around $9.5–11B and long‑term debt sits near $2.3–2.5B, yielding a balance sheet with solid equity (around $2.5–3.1B). Current liabilities and assets are balanced enough to sustain operations, providing resilience through moderate liquidity headroom. ⚠️ Key Drivers & Risks
|